Prot# H4320//NU 10C03: Phase I/II Dose Escalation Trial to Assess Safety of Intrathecal Trastuzumab for the Treatment of Leptomeningeal Metastases in HER2 Positive Breast Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date4/22/1112/31/20

Funding

  • Genentech, Inc. (H4320//NU 10C03)